Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
| Revision | Operations | |
|---|---|---|
| 08-12-20 by conan.macdougal... | current revision | |
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 07-10-20 by [email protected] | ||
| 07-7-20 by [email protected] | ||
| 04-17-20 by ucsf_admin | ||
| 02-5-20 by ucsf_admin | ||
| 02-4-20 by ucsf_admin | ||
| 02-4-20 by ucsf_admin | ||
| 02-4-20 by ucsf_admin | ||
Dosing: Adult Antimicrobial Dosing, Non-dialysis
| Indication | Dose | Notes |
|---|---|---|
| Community-acquired pneumonia, ICU | 500 mg IV/PO q24h | No adjustment for renal dysfunction |
| Community-acquired pneumonia, non-ICU | 500 mg IV/PO x1 then 250 mg IV/PO q24h |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
| Indication | Dose | Notes |
|---|---|---|
| Community-acquired pneumonia, ICU | 500 mg IV/PO q24h | No adjustment for dialysis |
| Community-acquired pneumonia, non-ICU | 500 mg IV/PO x1 then 250 mg IV/PO q24h |
Dialysis Notes
Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. For detailed view of dialysis dosing and evidence, see Dosing in Hemodialysis document.